title: Adverse reaction after tetrathiomolybdate treatment for Wilson's disease: a case report.
authors.forename: Valentina
authors.initials: V
authors.lastname: Medici
authors.forename: Carlo Pietro
authors.initials: CP
authors.lastname: Trevisan
authors.forename: Maria Assunta
authors.initials: MA
authors.lastname: Bigotto
authors.forename: Renata
authors.initials: R
authors.lastname: D'Incà
authors.forename: Diego
authors.initials: D
authors.lastname: Martines
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Dal Pont
authors.forename: Giacomo Carlo
authors.initials: GC
authors.lastname: Sturniolo
mesh_terms: D000328:Adult; D003300:Copper / Q000652:urine; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D006527:Hepatolenticular Degeneration / Q000188:drug therapy* / Q000652:urine; D006801:Humans; D008297:Male; D008982:Molybdenum / Q000009:adverse effects*; D015032:Zinc / Q000652:urine
chemical_list: D004791:Enzyme Inhibitors; D003300:Copper; D008982:Molybdenum; C020809:tetrathiomolybdate; D015032:Zinc